Patents by Inventor Wei-Chi Liao

Wei-Chi Liao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230195188
    Abstract: Methods and systems for thermal management of hardware resources that may be used to provide computer implemented services are disclosed. The disclosed thermal management method and systems may improve the likelihood of data processing systems providing desired computer implemented services by improving the thermal management of the hardware resources without impairment of storage devices. To improve the likelihood of the computer implemented services being provided, the systems may proactively identify whether storage devices subject to impairment due to dynamic motion are present. If such storage devices are present, then the system may automatically take action to reduce the likelihood of the storage devices being subject to dynamic motion sufficient to impair their operation.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 22, 2023
    Inventors: HUNG-PIN CHIEN, JYH-YINN LIN, YU-WEI CHI LIAO, CHIEN YEN HSU, MING-HUI PAN
  • Patent number: 5827525
    Abstract: A unidirectional buccal delivery system for the delivery of therapeutic agents over an extended period of time. The delivery system includes a matrix for releasing the drug into the oral cavity at a sustained rate and a means for securing the matrix to the palate or other adequate regions in the oral cavity.
    Type: Grant
    Filed: September 10, 1996
    Date of Patent: October 27, 1998
    Assignee: Bristol-Myers Squibb Company
    Inventors: Wei-Chi Liao, Agis Kydonieus, Kishore R. Shah
  • Patent number: 5720950
    Abstract: The present invention concerns a method for treating fibrotic conditions by administration of an effective amount of an antifibrotic agent. The antifibrotic agent is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). The antifibrotic agent is operatively linked to a monomer or a polymer, with or without a linking compound, e.g., lysine. Intravenous administration is preferred. The present method facilitates the delivery and release of the antifibrotic agent to inhibit collagen accumulation and thereby to treat fibrosis where collagen metabolism is implicated. A reduced quantity of the antifibrotic agent and a corresponding reduction in the potential for toxicity resulting from prolonged administration thereof may be realized.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: February 24, 1998
    Assignee: University of Medicine & Dentistry of New Jersey
    Inventors: George J. Poiani, David J. Riley, Wei-Chi Liao, Joachim Kahn, Keria Fiorella Gean
  • Patent number: 5660822
    Abstract: The present invention concerns a method for treating fibrotic conditions by administration of an effective amount of an antifibrotic agent. The antifibrotic agent is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). The antifibrotic agent is operatively linked to a monomer or a polymer, with or without a linking compound, e.g., lysine. Intravenous administration is preferred. The present method facilitates the delivery and release of the antifibrotic agent to inhibit collagen accumulation and thereby to treat fibrosis where collegen metabolism is implicated. A reduced quantity of the antifibrotic agent and a corresponding reduction in the potential for toxicity resulting from prolonged administration thereof may be realized.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 26, 1997
    Assignees: University of Medicine & Dentistry of N.J., Rutgers University
    Inventors: George J. Poiani, David J. Riley, Wei-Chi Liao, Joachim Kahn, Keria Fiorella Gean
  • Patent number: 5372807
    Abstract: The present invention concerns a method for treating fibrotic conditions by administration of an effective amount of an antifibrotic agent. The antifibrotic agent is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). The antifibrotic agent is operatively linked to a monomer or a polymer, with or without a linking compound, e.g., lysine. Intravenous administration is preferred. The present method facilitates the delivery and release of the antifibrotic agent to inhibit collagen accumulation and thereby to treat fibrosis where collegen metabolism is implicated. A reduced quantity of the antifibrotic agent and a corresponding reduction in the potential for toxicity resulting from prolonged administration thereof may be realized.
    Type: Grant
    Filed: August 24, 1992
    Date of Patent: December 13, 1994
    Assignees: University of Medicine and Dentistry of New Jersey, Rutgers University
    Inventors: George J. Poiani, David J. Riley, Wei-Chi Liao, Joachim Kahn, Keria F. Gean
  • Patent number: 3983642
    Abstract: This invention relates to shoes. It's object is to provide improved securing forms which are adapted to interchangeable uppers so that the appearance of shoes may be changed completely by only changing the uppers. These forms are (1) body-hook form (2) string-hole form (3) looped strap form (4) plug form (5) halter form (6) harness form and (7) belt form.
    Type: Grant
    Filed: December 4, 1974
    Date of Patent: October 5, 1976
    Inventor: Wei-Chi Liao